8,577 Shares in Nutrien Ltd. (NYSE:NTR) Purchased by Nebula Research & Development LLC

Nebula Research & Development LLC bought a new position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 8,577 shares of the company's stock, valued at approximately $384,000.

A number of other institutional investors and hedge funds have also bought and sold shares of NTR. Uncommon Cents Investing LLC grew its stake in Nutrien by 2.1% in the 4th quarter. Uncommon Cents Investing LLC now owns 11,550 shares of the company's stock valued at $517,000 after buying an additional 235 shares during the last quarter. Rhumbline Advisers grew its position in shares of Nutrien by 3.5% in the fourth quarter. Rhumbline Advisers now owns 7,398 shares of the company's stock valued at $331,000 after purchasing an additional 247 shares during the last quarter. FFT Wealth Management LLC increased its stake in shares of Nutrien by 0.9% during the fourth quarter. FFT Wealth Management LLC now owns 29,732 shares of the company's stock worth $1,330,000 after purchasing an additional 277 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in Nutrien by 23.9% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,804 shares of the company's stock worth $81,000 after purchasing an additional 348 shares during the last quarter. Finally, PFG Investments LLC boosted its stake in Nutrien by 2.0% in the 4th quarter. PFG Investments LLC now owns 20,097 shares of the company's stock valued at $899,000 after purchasing an additional 386 shares during the period. Institutional investors own 63.10% of the company's stock.

Nutrien Trading Up 0.2 %

NTR stock traded up $0.11 during midday trading on Friday, hitting $56.85. The stock had a trading volume of 2,166,126 shares, compared to its average volume of 2,120,169. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. The firm has a market cap of $27.76 billion, a P/E ratio of 41.50, a price-to-earnings-growth ratio of 1.19 and a beta of 0.79. The business has a fifty day moving average price of $51.50 and a two-hundred day moving average price of $49.68. Nutrien Ltd. has a 1-year low of $43.70 and a 1-year high of $60.87.

Nutrien (NYSE:NTR - Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.37 by ($0.09). The business had revenue of $5.08 billion for the quarter, compared to the consensus estimate of $5.09 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. On average, sell-side analysts predict that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.

Nutrien Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, April 10th. Stockholders of record on Monday, March 31st were paid a $0.545 dividend. The ex-dividend date of this dividend was Monday, March 31st. This represents a $2.18 dividend on an annualized basis and a dividend yield of 3.83%. Nutrien's payout ratio is presently 159.12%.

Analysts Set New Price Targets

NTR has been the subject of a number of recent research reports. The Goldman Sachs Group initiated coverage on shares of Nutrien in a research report on Thursday, March 13th. They issued a "sell" rating and a $53.00 target price for the company. Scotiabank increased their target price on shares of Nutrien from $60.00 to $62.00 and gave the stock a "sector outperform" rating in a research report on Monday, February 24th. BNP Paribas upgraded shares of Nutrien to a "strong-buy" rating in a research report on Wednesday, April 9th. Barclays boosted their price target on Nutrien from $56.00 to $59.00 and gave the company an "equal weight" rating in a research note on Wednesday, March 5th. Finally, UBS Group lowered their price objective on Nutrien from $54.00 to $52.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 16th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $59.27.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.